Literature DB >> 15044485

Dissection of amyloid-beta precursor protein-dependent transcriptional transactivation.

Xinwei Cao1, Thomas C Südhof.   

Abstract

Amyloid-beta precursor protein (APP) forms a transcriptionally active complex with the adaptor protein Fe65 and the histone acetyltransferase Tip60, but the mechanism of transcriptional activation that is mediated by APP and Fe65 remains unclear. APP is cleaved by gamma-secretase similar to Notch, whose intracellular domain activates transcription by interacting with nuclear transcription factors. To test whether the APP intracellular domain (AICD) functions analogously, we investigated how APP and Fe65 transactivate a Gal4 fusion protein of Tip60. Consistent with the Notch paradigm, we observe that gamma-cleavage of APP and nuclear translocation of Fe65 are required for transactivation. Surprisingly, however, we find that nuclear translocation of the AICD may be dispensable and that only membrane-tethered AICD (i.e. AICD coupled to a transmembrane region) and not free AICD (i.e. soluble AICD) is a potent transactivator of transcription. Membrane-tethered AICD recruits Fe65 and mediates the activation of bound Fe65 that is then released for nuclear translocation by gamma-cleavage together with the AICD. Our data suggest that transcriptional transactivation by APP and Notch may involve distinct mechanisms; whereas the Notch intracellular domain directly functions in the nucleus, the AICD acts indirectly by activating Fe65.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15044485     DOI: 10.1074/jbc.M402248200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  113 in total

Review 1.  Synapses and Alzheimer's disease.

Authors:  Morgan Sheng; Bernardo L Sabatini; Thomas C Südhof
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-05-01       Impact factor: 10.005

Review 2.  Disease-modifying therapies in Alzheimer's disease: how far have we come?

Authors:  Michael Hüll; Mathias Berger; Michael Heneka
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 3.  The amyloid-beta precursor protein: integrating structure with biological function.

Authors:  Constanze Reinhard; Sébastien S Hébert; Bart De Strooper
Journal:  EMBO J       Date:  2005-10-27       Impact factor: 11.598

4.  Transcription regulation by the adaptor protein Fe65 and the nucleosome assembly factor SET.

Authors:  Francesca Telese; Paola Bruni; Aldo Donizetti; Davide Gianni; Chiara D'Ambrosio; Andrea Scaloni; Nicola Zambrano; Michael G Rosenfeld; Tommaso Russo
Journal:  EMBO Rep       Date:  2005-01       Impact factor: 8.807

5.  A {gamma}-secretase-independent mechanism of signal transduction by the amyloid precursor protein.

Authors:  Matthew R Hass; Bruce A Yankner
Journal:  J Biol Chem       Date:  2005-08-15       Impact factor: 5.157

6.  Tuning of Glutamate, But Not GABA, Release by an Intrasynaptic Vesicle APP Domain Whose Function Can Be Modulated by β- or α-Secretase Cleavage.

Authors:  Wen Yao; Marc D Tambini; Xinran Liu; Luciano D'Adamio
Journal:  J Neurosci       Date:  2019-06-24       Impact factor: 6.167

Review 7.  Presenilin: RIP and beyond.

Authors:  Matthew R Hass; Chihiro Sato; Raphael Kopan; Guojun Zhao
Journal:  Semin Cell Dev Biol       Date:  2008-11-27       Impact factor: 7.727

8.  Presenilin/gamma-secretase cleaves CD46 in response to Neisseria infection.

Authors:  Nathan J Weyand; Christine M Calton; Dustin L Higashi; Kristen J Kanack; Magdalene So
Journal:  J Immunol       Date:  2009-12-16       Impact factor: 5.422

9.  Netrin-1 interacts with amyloid precursor protein and regulates amyloid-beta production.

Authors:  F C Lourenço; V Galvan; J Fombonne; V Corset; F Llambi; U Müller; D E Bredesen; P Mehlen
Journal:  Cell Death Differ       Date:  2009-01-16       Impact factor: 15.828

10.  Cortical dysplasia resembling human type 2 lissencephaly in mice lacking all three APP family members.

Authors:  Jochen Herms; Brigitte Anliker; Sabine Heber; Sabine Ring; Martin Fuhrmann; Hans Kretzschmar; Sangram Sisodia; Ulrike Müller
Journal:  EMBO J       Date:  2004-09-23       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.